Hennion & Walsh Asset Management, Inc. Day One Biopharmaceuticals, Inc. Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.35 Billion
- Q2 2025
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 96,821 shares of DAWN stock, worth $594,480. This represents 0.03% of its overall portfolio holdings.
Number of Shares
96,821
Previous 137,968
29.82%
Holding current value
$594,480
Previous $1.11 Million
43.49%
% of portfolio
0.03%
Previous 0.05%
Shares
9 transactions
Others Institutions Holding DAWN
# of Institutions
188Shares Held
69.3MCall Options Held
127KPut Options Held
85.5K-
Atlas Venture Life Science Advisors, LLC6.43MShares$39.5 Million9.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.18MShares$37.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$27.8 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA4.1MShares$25.2 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.72MShares$22.9 Million0.56% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $451M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...